Scynexis Names Sanjay Subramanian CFO
(RTTNews) - Scynexis Inc. (SCYX), a clinical-stage biotechnology company focused on severe rare diseases, on Thursday appointed Sanjay Subramanian as Chief Financial Officer, effective September 9.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.